Petter Bjorquist, Ph.D., CEO Oct. 10 | 9:45am | Rentschler ATMP Ballroom Gothenburg, Sweden (Private) VERIGRAFT AB is a Swedish biotechnology company run by experienced entrepreneurs and mastering a unique, breakthrough technology in the field of advanced therapies and regenerative medicine. We make transplantation possible without the severe risks...
Philip Toleikis, Ph.D., President and CEO Oct. 11 | 5:30pm | Aseptic Technologies Ballroom London, Ontario (NASDAQ: SVA) Sernova Corp is a clinical-stage biotechnology company developing therapeutic cell technologies with a goal to deliver a ‘functional cure’ for chronic diseases, including insulin-dependent diabetes, thyroid disease and hemophilia A. Sernova...
Tim Lu, M.D, Ph.D., CEO and Co-Founder Oct. 11 | 3:15pm | Ecolab Life Sciences Ballroom South San Francisco, CA (NASDAQ: SNTI) Senti's mission is to create a new generation of smarter medicines that outmaneuver incurable diseases using the Gene Circuit technology. We utilize off-the-shelf chimeric antigen receptor natural...
Curran Simpson, Chief Operating Officer Oct. 11 | 5:00pm | Aseptic Technologies Ballroom Rockville, Maryland (NASDAQ: RGNX) REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of...
Cindy Atwell, Chief Business Officer Oct. 10 | 3:00pm | Ecolab Life Sciences Ballroom Durham, NC (NASDAQ: DTIL) Precision BioSciences, Inc., is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome...
Antonio Lee, Ph.D., CEO Oct. 11 | 5:00pm | Ecolab Life Sciences Ballroom Boston, MA (Private) MEDIPOST is found in 2000 and headquartered in Korea and became a public company in 2005 listed in KOSDAQ with around 300 employees. The wholly-owned U.S. subsidiary (MEDIPOST Inc.) is located in Boston,...
Mark Sawicki, Ph.D., President and CEO Oct. 12 | 9:30am | Ecolab Life Sciences Ballroom Brentwood, TN (NASDAQ: CYRX) Cryoport Systems is the premier provider of temperature-controlled supply chain solutions for the life sciences industry. We proudly offer the most comprehensive solutions to support research, clinical trials and commercial...
Steven Kelly, CEO Oct. 10 | 4:30pm | Ecolab Life Sciences Ballroom Philadelphia, PA (NASDAQ: CARM) Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have...
Steven Nichtberger, M.D., President and CEO Oct. 10 | 10:45am | Ecolab Life Sciences Ballroom Philadelphia, PA (NASDAQ: CABA) Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative,...
Brent Rice, Chief Commercial Officer Oct. 11 | 4:15pm | Aseptic Technologies Ballroom London, UK (NASDAQ: AUTL) In-person Presentation Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing benefits to...
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.
October 7-9, 2024
Arizona Biltmore
Phoenix, AZ
